160 related articles for article (PubMed ID: 19169862)
81. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332
[TBL] [Abstract][Full Text] [Related]
82. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
83. Two-port pars plana vitrectomy surgery: a prospective interventional case series.
Colucciello M
Eye (Lond); 2005 Aug; 19(8):869-72. PubMed ID: 15359245
[TBL] [Abstract][Full Text] [Related]
84. [Minimally invasive vitrectomy for the treatment of severe proliferative diabetic retinopathy].
Zheng CZ; Ren XJ; Ke YF; Wen DJ; Li XR
Zhonghua Yan Ke Za Zhi; 2021 Jun; 57(6):440-446. PubMed ID: 34098693
[No Abstract] [Full Text] [Related]
85. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
[TBL] [Abstract][Full Text] [Related]
86. Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial.
Aleman I; Castillo Velazquez J; Rush SW; Rush RB
Br J Ophthalmol; 2019 Dec; 103(12):1740-1746. PubMed ID: 30705040
[TBL] [Abstract][Full Text] [Related]
87. Preoperative electroretinogram and postoperative visual outcome in patients with diabetic vitreous hemorrhage.
Hiraiwa T; Horio N; Terasaki H; Suzuki T; Yamamoto E; Horiguchi M; Miyake Y
Jpn J Ophthalmol; 2003; 47(3):307-11. PubMed ID: 12782170
[TBL] [Abstract][Full Text] [Related]
88. Efficacy of higher cutting rates during microincision vitrectomy for proliferative diabetic retinopathy.
Sano M; Inoue M; Itoh Y; Hirota K; Koto T; Hirakata A
Eur J Ophthalmol; 2016 Jun; 26(4):364-8. PubMed ID: 26692058
[TBL] [Abstract][Full Text] [Related]
89. Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage.
Yilmaz U; Akçaoğlu T; Avunduk MA; Kaya H; Parça O
Medicine (Baltimore); 2024 Jan; 103(3):e36963. PubMed ID: 38241585
[TBL] [Abstract][Full Text] [Related]
90. Vitrectomy for severe diabetic eye disease.
McLeod D; Leaver PK; Feretis E
Trans Ophthalmol Soc U K (1962); 1980 Jul; 100(Pt 2):291-8. PubMed ID: 6943852
[No Abstract] [Full Text] [Related]
91. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
[TBL] [Abstract][Full Text] [Related]
92. Vitreous Wiping, a new technique for removal of vitreous cortex remnants during vitrectomy.
van Overdam KA; van Etten PG; van Meurs JC; Manning SS
Acta Ophthalmol; 2019 Aug; 97(5):e747-e752. PubMed ID: 30536726
[TBL] [Abstract][Full Text] [Related]
93. Surgery for Diabetic Eye Complications.
Berrocal MH; Acaba LA; Acaba A
Curr Diab Rep; 2016 Oct; 16(10):99. PubMed ID: 27612846
[TBL] [Abstract][Full Text] [Related]
94. Vitreous rebleeding rate after vitrectomy or phacovitrectomy in patients with proliferative diabetic retinopathy: A retrospective study.
García-Luna S; Pita-Ortíz IY; Quevedo-Martínez JU; Somilleda-Ventura SA; Pérez-Cano HJ
Arch Soc Esp Oftalmol (Engl Ed); 2024 Feb; 99(2):62-66. PubMed ID: 38013130
[TBL] [Abstract][Full Text] [Related]
95. Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial.
Rush RB; Velazquez JC; Rosales CR; Rush SW
Am J Ophthalmol; 2022 Oct; 242():173-180. PubMed ID: 35764103
[TBL] [Abstract][Full Text] [Related]
96. Management of postvitrectomy diabetic vitreous hemorrhage with volume homeostatic fluid-fluid exchanger.
Wu WC; Chen JY; Chen YC; Chang YC
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1183-9. PubMed ID: 19421765
[TBL] [Abstract][Full Text] [Related]
97. Analysis of Prognostic Factors in Non-Traumatic and Non-Diabetic Retinopathy Patients Undergoing Vitrectomy.
Dong M; Xiao Q; Liu C; Fan B; Han R
Ann Ital Chir; 2024; 95(3):322-329. PubMed ID: 38918969
[TBL] [Abstract][Full Text] [Related]
98. [Preretinal hemorrhage and prognosis following vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy].
Li JK; Jin XH; Fang W; Feng LG; Zhai J; Li YM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 44(2):167-73. PubMed ID: 26038135
[TBL] [Abstract][Full Text] [Related]
99. Ultrasonic fragmentation for removing thick organized clots during diabetic vitrectomy - A novel technique.
Singh DV; Reddy RR; Upadhyay A; Sharma YR
Indian J Ophthalmol; 2022 Jun; 70(6):2184-2186. PubMed ID: 35648011
[TBL] [Abstract][Full Text] [Related]
100. Papilledema detected by ultrasound in proliferative diabetic retinopathy with vitreous hemorrhage.
Zhao MY; Charoenkijkajorn C; Pakravan M; Kavoussi SC; Lee AG
Can J Ophthalmol; 2023 Jun; 58(3):e141-e143. PubMed ID: 36549652
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
